4//SEC Filing
Diaz Allene M. 4
Accession 0000874015-25-000180
CIK 0000874015other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:23 PM ET
Size
5.2 KB
Accession
0000874015-25-000180
Insider Transaction Report
Form 4
Diaz Allene M.
Director
Transactions
- Sale
Common Stock
2025-08-22$42.53/sh−1,427$60,687→ 18,368 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 3, 2023
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.30 to $42.75 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001773314
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:23 PM ET
- Size
- 5.2 KB